Bruker Corporation

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 17/07/2024 BST			5-day change	1st Jan Change
64.09 ^USD	-3.26%		+4.64%	-12.78%

07-09	Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating	MT
07-02	Bruker Corporation Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut Für Molekulare Pharmakologie in Berlin	CI

Bruker Corporation acquired SCiLS GmbH.

January 03, 2017

Bruker Corporation (NasdaqGS:BRKR) acquired SCiLS GmbH on January 4, 2017. Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of SCiLS GmbH on January 4, 2017.

Latest news about Bruker Corporation

Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating	07-09	MT
Bruker Corporation Announces Successful Installation of a 1.2 GHz NMR at the Leibniz Forschungsinstitut Für Molekulare Pharmakologie in Berlin	07-02	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell Small Cap Comp Value Index	06-30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell Midcap Value Index	06-30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 3000E Value Index	06-30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 2500 Value Index	06-30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 3000 Value Index	06-30	CI
Bruker Corporation(NasdaqGS:BRKR) dropped from Russell 1000 Growth-Defensive Index	06-30	CI
Bruker Corporation(NasdaqGS:BRKR) dropped from Russell 1000 Defensive Index	06-30	CI
Bruker Corporation(NasdaqGS:BRKR) added to Russell 1000 Value Index	06-30	CI
Cellens, Inc. Announces Collaboration with Bruker BioAFM to Advance Mechanobiology Technology for Cancer Detection	06-25	CI
Transcript : Bruker Corporation Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 11:20 AM	06-12
Transcript : Bruker Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 07:30 AM	06-06
Bruker Corporation Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics	06-03	CI
Bruker Corporation Launches Transformative neofleX? MALDI-TOF System for Spatial Biology Mass Spec Imaging Applications	06-03	CI
Bruker Prices Offering of 6 Million Shares	05-30	MT
Bruker Shares Fall Following Public Offering of 6 Million Shares	05-29	MT
Stifel Adjusts Price Target on Bruker to $77 From $81, Maintains Hold Rating	05-20	MT
Transcript : Bruker Corporation - Special Call	05-17
Bruker Keeps Quarterly Dividend at $0.05 Per Share; Payable June 17 to Shareholders of Record on June 3	05-15	MT
Bruker Corporation Announces Quarterly Dividend, Payable on June 17, 2024	05-15	CI
Bruker's NanoString Secures Patent Case Win in Germany	05-07	MT
Bruker Corporation completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.	05-05	CI
Bruker Shares Fall After Q1 Revenue Misses Consensus Views; Lifts Full-Year Guidance	05-02	MT
Transcript : Bruker Corporation, Q1 2024 Earnings Call, May 02, 2024	05-02

Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.

Sector

Advanced Medical Equipment & Technology

Calendar

31/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Bruker Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

64.09 USD

Average target price

80.91 USD

Spread / Average Target

+26.25%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
BRUKER CORPORATION	-12.78%	9.7B
THERMO FISHER SCIENTIFIC	+4.57%	212B
DANAHER CORPORATION	+8.61%	186B
INTUITIVE SURGICAL, INC.	+26.34%	151B
BOSTON SCIENTIFIC CORPORATION	+33.90%	114B
SIEMENS HEALTHINEERS AG	+3.46%	65.57B
EDWARDS LIFESCIENCES CORPORATION	+14.50%	52.61B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.30%	46.8B
AGILENT TECHNOLOGIES, INC.	-3.98%	38.95B
GE HEALTHCARE TECHNOLOGIES INC.	+6.66%	37.64B

Other Advanced Medical Equipment & Technology